Chronic Pelvic Pain and Sexual Dysfunction Among Females and Males Receiving Treatment for Opioid Use Disorder

Introduction: Chronic pain brings complexity to opioid use disorder (OUD). Psychosocial and neurobiological risks for Chronic Pelvic Pain (CPP) and OUD overlap. The primary objective of this exploratory study is to compare sex-specific prevalence of CPP and sexual dysfunction between individuals receiving buprenorphine for OUD and a comparison group receiving treatment for other chronic medical conditions (CMC).Methods: Participants from an OUD treatment (n = 154) and primary care clinic (n = 109) completed a survey between July 2019 and February 2020 assessing reproductive and sexual health. Sex-stratified CPP and pain interference measures were adapted from the Brief Pain Inventory for females, and for males, the Brief Male Sexual Function Inventory and NIH Chronic Prostatitis Symptom Index. The Male and Female Sexual Function Index assessed sexual dysfunction. Prevalence of CPP and sexual dysfunction between groups were compared using Pearson χ2 and Fisher's Exact tests.Results: Participants were 54.4% female and 75.0% Black with almost half having a psychiatric diagnosis. Among OUD females, the highest pain severity reported was for menstrual-related pain, and for OUD males, testicular pain. CPP most interfered with mood in OUD females vs. sleep and enjoyment of life in OUD males. There were no differences in prevalence for global sexual dysfunction with 91.6% of females and 84.2% of males screening positive across groups.Discussion/Implications: CPP and sexual dysfunction are important components of wellness and may play a role in OUD recovery trajectories. The value of addressing CPP and sexual dysfunction in tailored comprehensive, sex-informed OUD treatment approaches should be further investigated.

Download Full-text

Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder

Journal of the American Psychiatric Nurses Association ◽

10.1177/1078390318805562 ◽

2018 ◽

Vol 25 (4) ◽

pp. 305-313

Author(s):

Matthew Tierney ◽

Katerina Melino ◽

Adebowale Adeniji ◽

Martha Shumway ◽

Isabel E. Allen ◽

...

Keyword(s):

Primary Care Clinic ◽

Opioid Use Disorder ◽

Treatment Retention ◽

Retention Rates ◽

Opioid Use ◽

Access To Treatment ◽

Care Clinic ◽

Similar Treatment ◽

Buprenorphine Treatment ◽

Treatment Settings

INTRODUCTION: There is considerable need for effective and accessible treatment for opioid use disorder. AIMS: Our study explored differences in buprenorphine treatment retention and duration, with a focus on selected sociodemographic factors and treatment indicators, in two different settings: an office-based buprenorphine induction and stabilization clinic (OBIC) and a community-based primary care clinic (CPC). METHOD: This nonexperimental retrospective chart review compared demographic information and buprenorphine treatment details, including treatment retention and duration. RESULTS: There were no statistically significant differences in buprenorphine treatment indicators between the OBIC and CPC groups, with two exceptions: the number of written buprenorphine prescriptions was significantly greater for the OBIC group, as was the number of filled buprenorphine prescriptions. CONCLUSIONS: Given similar treatment retention and duration in two different buprenorphine treatment settings, our findings suggest that access to buprenorphine treatment in standard integrated care settings can be supplemented by novel treatment structures such as the OBIC in order to increase access to care during the current opioid epidemic.

Download Full-text

229: Sexual Function in Ethnically Diverse Men with Category III Prostatitis / Chronic Pelvic Pain Syndrome

The Journal of Urology ◽

10.1016/s0022-5347(18)37491-3 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 60-60

Author(s):

Zeph Okeke ◽

Konstantin Walmsley ◽

Alexis E. Te ◽

Steven A. Kaplan

Keyword(s):

Sexual Function ◽

Pelvic Pain ◽

Chronic Pelvic Pain ◽

Chronic Pelvic Pain Syndrome ◽

Ethnically Diverse ◽

Pain Syndrome ◽

Pelvic Pain Syndrome

Download Full-text

Differential approach to symptomatic treatment of micturition disorders and sexual dysfunction in patients with chronic pelvic pain syndrome

Experimental and Сlinical Urology ◽

10.29188/2222-8543-2019-11-1-120-127 ◽

2019 ◽

Vol 11 (1) ◽

pp. 120-127

Author(s):

A.V. Sivkov ◽

◽

V.V. Romikh ◽

A.V. Zakharchenko ◽

L.Yu Borisenko ◽

...

Keyword(s):

Sexual Dysfunction ◽

Pelvic Pain ◽

Chronic Pelvic Pain ◽

Chronic Pelvic Pain Syndrome ◽

Pain Syndrome ◽

Symptomatic Treatment ◽

Pelvic Pain Syndrome ◽

Differential Approach ◽

Micturition Disorders

Download Full-text

373The evaluation of the effect of alpha blockers and antibiotics in chronic prostatitis/chronic pelvic pain syndrome and the assessment of the results with the chronic prostatitis symptom index

European Urology Supplements ◽

10.1016/s1569-9056(05)80379-3 ◽

2005 ◽

Vol 4 (3) ◽

pp. 96

Author(s):

C. Adayener ◽

F. Ates ◽

K. Karademir ◽

T. Senkul ◽

C. Iseri ◽

...

Keyword(s):

Pelvic Pain ◽

Chronic Prostatitis ◽

Chronic Pelvic Pain ◽

Chronic Pelvic Pain Syndrome ◽

Pain Syndrome ◽

Pelvic Pain Syndrome ◽

Symptom Index ◽

Alpha Blockers

Download Full-text

Methadone Distribution Trends from 2017-2019 in the United States

10.1101/2020.11.07.20227496 ◽

2020 ◽

Author(s):

John A. Furst ◽

Nicholas J. Mynarski ◽

Kenneth L. McCall ◽

Brian J. Piper

Keyword(s):

United States ◽

Rhode Island ◽

Distribution Patterns ◽

The United States ◽

Opioid Use Disorder ◽

Primary Objective ◽

Treatment Programs ◽

Opioid Use ◽

Drug Enforcement ◽

The Us

AbstractObjectiveMethadone is an evidence based treatment for opioid use disorder and is also employed for acute pain. The primary objective of this study was to explore methadone distribution patterns between the years 2017 and 2019 across the United States (US). This study builds upon previous literature that has analyzed prior years of US distribution patterns, and further outlines regional and state specific methadone trends.MethodsThe Drug Enforcement Administration’s Automated Reports and Consolidated Ordering System (ARCOS) was used to acquire the number of narcotic treatment programs (NTPs) per state and methadone distribution weight in grams. Methadone distribution by weight, corrected for state populations, and number of NTPs were compared from 2017 to 2019 between states, within regions, and nationally.ResultsBetween 2017 and 2019, the national distribution of methadone increased 12.30% for NTPs but decreased 34.57% for pain, for a total increase of 2.66%. While all states saw a decrease in distribution for pain, when compared regionally, the Northeast showed a significantly smaller decrease than all other regions. Additionally, the majority of states experienced an increase in distribution for NTPs and most states demonstrated a relatively stable or increasing number of NTPs, with an 11.49% increase in NTPs nationally. The number of NTPs per 100K in 2019 ranged from 2.08 in Rhode Island to 0.00 in Wyoming.ConclusionAlthough methadone distribution for OUD was increasing in the US, there were pronounced regional disparities.

Download Full-text

626 THE INFLUENCE OF DEPRESSION AND OF PAIN INTENSITY ON THE SEXUAL FUNCTION OF WOMEN WITH CHRONIC PELVIC PAIN

European Journal of Pain ◽

10.1016/s1090-3801(09)60629-7 ◽

2009 ◽

Vol 13 (S1) ◽

Author(s):

A. Romão ◽

P. Souza ◽

O. Poli Neto ◽

J. Rosa Silva ◽

F. Reis ◽

...

Keyword(s):

Sexual Function ◽

Pain Intensity ◽

Pelvic Pain ◽

Chronic Pelvic Pain

Download Full-text

Stigma of Opioid Use Disorder and Its Indirect Effects on Student Pharmacists’ Perceptions and Attitudes

Pharmacy ◽

10.3390/pharmacy8030144 ◽

2020 ◽

Vol 8 (3) ◽

pp. 144

Author(s):

Elizabeth A. Hall ◽

Alina Cernasev ◽

Umida Nasritdinova ◽

Michael P. Veve ◽

Kenneth C. Hohmeier

Keyword(s):

Community Pharmacy ◽

Student Perceptions ◽

Opioid Use Disorder ◽

Vital Role ◽

Primary Objective ◽

Community Resources ◽

Opioid Use ◽

Opioid Prescription ◽

Electronic Survey ◽

Perceptions And Attitudes

Objectives: Pharmacists play a vital role in serving patients during the ongoing nationwide opioid epidemic, and so it is also critical to educate the next generation of pharmacists on opioids and opioid use disorder (OUD). The primary objective of this study was to quantitatively characterize student perceptions of opioid use and the stigma associated with OUD. Secondary aims were to determine whether differences in perceptions exist based upon the student’s year in the Doctor of Pharmacy program or employment in a community pharmacy. Methods: First-, second-, third-, and fourth-year student pharmacists voluntarily completed an electronic survey regarding perceptions of opioid use and stigma associated with OUD. Results: Of the 9 survey items, students were most uncomfortable referring patients to community resources for addiction support and/or treatment (25.3% comfortable or very comfortable). Students working in a community pharmacy were significantly more comfortable talking to patients attempting to refill opioids early and providing opioid counseling as compared to their peers not working in community pharmacy. Fourth-year students reported a higher level of comfort talking to a patient attempting to refill an opioid prescription early, counseling a patient on an opioid prescription, and providing information about alternatives to opioids. Third-year students responded most favorably to the items regarding how well the curriculum has prepared them to interact with patients taking opioids and those with OUD. Conclusions: These findings reveal that students are comfortable counseling on opioids and discussing alternative options. Differences in perceptions were observed based upon the student’s year in the program and whether or not they were employed in a community pharmacy setting.

Download Full-text